Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

Author(s): Dinkova-Kostova AT, Liby KT, Stephenson KK, Holtzclaw WD, Gao X, et al.

Abstract

A series of synthetic triterpenoid (TP) analogues of oleanolic acid are powerful inhibitors of cellular inflammatory processes such as the induction by IFN-gamma of inducible nitric oxide synthase (iNOS) and of cyclooxygenase 2 in mouse macrophages. Here, we show that these analogues are also extremely potent inducers of the phase 2 response [e.g., elevation of NAD(P)H-quinone oxidoreductase and heme oxygenase 1], which is a major protector of cells against oxidative and electrophile stress. Moreover, like previously identified phase 2 inducers, the TP analogues use the antioxidant response element-Nrf2-Keap1 signaling pathway. Thus, induction of the phase 2 response and suppression of the iNOS induction was abrogated in nrf2(-/-) and keap1(-/-) mouse embryonic fibroblasts. The high potency of TP analogues in inducing the phase 2 response and blocking inflammation depends on the presence of activated Michael reaction (enone) functions at critical positions in rings A and C. The most potent TP doubles NAD(P)H-quinone oxidoreductase in murine hepatoma cells at 0.28 nM and has an IC(50) for suppression of iNOS induction in primary mouse macrophages of 0.0035 nM. The direct interaction of this TP with thiol groups of the Keap1 sensor for inducers is demonstrated spectroscopically. The antiinflammatory and phase 2 inducer potencies of 18 TP are closely linearly correlated (r(2) = 0.91) over 6 orders of magnitude of concentration. Thus, in addition to blocking inflammation and promoting differentiation, these TP exhibit another very important protective property: the induction of the phase 2 response.

Similar Articles

Global and societal implications of the diabetes epidemic

Author(s): Zimmet P, Alberti KG, Shaw J

Diabetic cardiomyopathy

Author(s): Murarka S, Movahed MR

Diabetic cardiomyopathy--a distinct disease? Best Pract Res Clin Endocrinol Metab 23: 347-360

Author(s): Khavandi K, Khavandi A, Asghar O, Greenstein A, Withers S, et al.

Oxidative stress and diabetic complications

Author(s): Giacco F, Brownlee M

Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2

Author(s): Hubbs AF, Benkovic SA, Miller DB, O'Callaghan JP, Battelli L, et al.

The transcription factor NRF2 protects against pulmonary fibrosis

Author(s): Cho HY, Reddy SP, Yamamoto M, Kleeberger SR